Synthesis and structure-activity relationships of a new model of arylpiperazines .3. 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo-[1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: Study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity

被引:39
作者
LopezRodriguez, ML
Morcillo, MJ
Fernandez, E
Porras, E
Murcia, M
Sanz, AM
Orensanz, L
机构
[1] UNIV NACL EDUC DISTANCIA, FAC CIENCIAS, E-28040 MADRID, SPAIN
[2] HOSP RAMON Y CAJAL, E-28034 MADRID, SPAIN
关键词
D O I
10.1021/jm970216k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new arylpiperazine derivatives 2, which are devoid of the terminal amide fragment present in related 5-HT1A ligands, was prepared and evaluated for affinity at 5-HT1A and alpha(1) receptors. All the compounds 2 demonstrated high affinity for the 5-HT1A receptor and moderate affinity for alpha(1) receptor binding sites. Structure-activity relationship (SAR) studies suggest that there is influence of electronic factors on the no-pharmacophoric part of the alpha(1) receptor site. However there is no influence of electronic interactions on the stabilization of the 5-HT1A receptor-ligand complex.
引用
收藏
页码:2653 / 2656
页数:4
相关论文
共 33 条
  • [1] [H-3]PRAZOSIN BINDING TO CENTRAL NERVOUS-SYSTEM REGIONS OF MALE AND FEMALE RATS
    AMBROSIO, E
    MONTERO, MT
    FERNANDEZ, I
    AZUARA, MC
    ORENSANZ, LM
    [J]. NEUROSCIENCE LETTERS, 1984, 49 (1-2) : 193 - 197
  • [2] [Anonymous], MED CHEM RES
  • [3] 5-HT AND ANTIDEPRESSANTS - NEW VIEWS FROM MICRODIALYSIS STUDIES
    ARTIGAS, F
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) : 262 - 262
  • [4] 5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS
    BARRETT, JE
    VANOVER, KE
    [J]. PSYCHOPHARMACOLOGY, 1993, 112 (01) : 1 - 12
  • [5] CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION
    BLIER, P
    DEMONTIGNY, C
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) : 220 - 226
  • [6] PROSPECTS FOR IMPROVED ANTIDEPRESSANTS
    BROEKKAMP, CLE
    LEYSEN, D
    PEETERS, BWMM
    PINDER, RM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (23) : 4615 - 4633
  • [7] 3-(omega-aminoalkyl)-5,5-dialkyl (or spirocycloalkyl-1',5-)hydantoins as new 5-HT1A and 5-HT2A receptor ligands
    Byrtus, H
    Pawlowski, M
    CharakchievaMinol, S
    Duszynska, B
    Mokrosz, MJ
    Mokrosz, JL
    Zejc, A
    [J]. ARCHIV DER PHARMAZIE, 1996, 329 (06) : 283 - 290
  • [8] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [9] MODELS OF 5-HYDROXYTRYPTAMINE RECEPTORS - A REVIEW
    CHILMONCZYK, Z
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (10) : 791 - 801
  • [10] 1,9-ALKANO-BRIDGED 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES WITH AFFINITY FOR THE ALPHA-2-ADRENOCEPTOR AND THE 5-HT1A RECEPTOR
    CLARK, RD
    WEINHARDT, KK
    BERGER, J
    FISHER, LE
    BROWN, CM
    MACKINNON, AC
    KILPATRICK, AT
    SPEDDING, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (02) : 633 - 641